Abeona Therapeutics Inc.
NASDAQAbeona Therapeutics heads into its May 13 earnings call with one of the most extreme short setups in the biotech universe — and a 25% monthly price rally making that position increasingly uncomfortable. Short sellers are deeply dug in. Short interest has climbed to 30% of the free float, up 5.7% over the past week alone after a brief dip in mid-April. The ORTEX short score is 83.5…
Snapshot as of 11 May 2026
Abeona Therapeutics heads into its May 13 earnings call with one of the most extreme short setups in the biotech universe — and a 25% monthly price rally making that position increasingly uncomfortable. Short sellers…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABEO — free to start on ORTEX.
Sign up for free →Open ABEO on ORTEX